LivaNova (LIVN) FCF Margin Growth (1y) (2017 - 2026)
LivaNova (LIVN) FCF Margin Growth (1y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.85 Bn | 194.25 Bn | 7.27 Bn | 194.00 |
| 2 | Stryker | 129.75 Bn | 126.28 Bn | 4.50 Bn | 66.00 |
| 3 | Medtronic | 119.86 Bn | 110.64 Bn | 6.41 Bn | -192.00 |
| 4 | Boston Scientific | 74.04 Bn | 73.50 Bn | 3.85 Bn | 119.00 |
| 5 | Edwards Lifesciences | 52.51 Bn | 48.26 Bn | 1.35 Bn | 1,788.00 |
| 6 | Dexcom | 34.75 Bn | 32.81 Bn | 830.00 Mn | -395.00 |
| 7 | GE HealthCare Technologies | 34.16 Bn | 32.05 Bn | 2.18 Bn | 112.00 |
| 8 | Koninklijke Philips | 26.43 Bn | 23.11 Bn | 4.55 Bn | -505.00 |
| 9 | Steris | 23.26 Bn | 22.78 Bn | 684.20 Mn | -473.00 |
| 10 | LivaNova | 4.32 Bn | 3.81 Bn | 273.67 Mn | -458.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -458.00 |
| Mar 31, 2026 | -285.00 |
| Dec 31, 2025 | -732.00 |
| Sep 30, 2025 | 705.00 |
| Jun 30, 2025 | 376.00 |
| Mar 31, 2025 | 294.00 |
| Dec 31, 2024 | 799.00 |
| Sep 30, 2024 | 703.00 |
| Jun 30, 2024 | 1,782.00 |
| Mar 31, 2024 | -375.00 |
| Dec 31, 2023 | 975.00 |
| Sep 30, 2023 | -843.00 |
| Jun 30, 2023 | -159.00 |
| Mar 31, 2023 | -362.00 |
| Dec 31, 2022 | -611.00 |
| Sep 30, 2022 | 355.00 |
| Jun 30, 2022 | -1,371.00 |
| Mar 31, 2022 | 403.00 |
| Dec 31, 2021 | -169.00 |
| Sep 30, 2021 | 893.00 |